Background--Glycemic index (GI) and glycemic load (GL) have been associated with coronary heart disease (CHD) risk in some but not all cohort studies. We therefore assessed the association of GI and GL with CHD risk in prospective cohorts.
The predominant concern in heart disease prevention has been saturated fatty acid (SFA) reduction, leading to widespread therapeutic adoption of low-total-fat, high-carbohydrate diets as the standard dietary approach for the reduction of coronary heart disease (CHD) risk. 2, 3 However, recent prospective cohort meta-analyses suggest an even greater increase in CHD risk when highly refined and readily absorbed carbohydrates replaced SFAs. 4, 5 As a result, SFAs per se no longer appeared to be associated with CHD, emphasizing the potentially deleterious effects of refined, rapidly absorbed carbohydrates. 4, 5 In addition, replacement of SFAs with unsaturated fatty acids and complex carbohydrates is associated with favorable changes in CHD risk factors. [6] [7] [8] These findings have intensified the focus on carbohydrates, because diets rich in highly processed carbohydrates can lead to raised triglycerides (TGs), 9 reductions in high-density lipoprotein cholesterol (HDL-C), 10 and increasing CHD risk.
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Carbohydrates with differing physical form, particle size, chemical structure, and fiber content alter the rate of starch digestion and their physiological response. The glycemic index (GI) was developed to characterize the rate of digestion of a carbohydrate food compared with a reference carbohydrate food. 12 Over the last 3 decades, clinical trials have demonstrated that reducing the GI or glycemic load (GL), the product of GI and the available carbohydrate content of a food, 13 in the context of diets low in saturated fat, can improve CHD risk factors including body mass index (BMI), blood pressure, and serum cholesterol. [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] Similar favorable effects have been seen with lower SFAs, higher poly-/ monounsaturated fatty acids, and higher complex carbohydrate diets. [6] [7] [8] These randomized controlled trials provide data that are harmonious with the emerging, albeit inconsistent, cohort literature on the unfavorable relationships between higher GI and GL dietary patterns and CHD risk. Cohort studies have also shown an association between low GI diets 25, 26 and reduced development of hyperglycemia and diabetes, further implicating the GI in the progression to CHD. 25, 26 This dietary pattern is also likely to have the additional advantage of reduced LDL cholesterol by lower intake of SFAs and dietary cholesterol. Despite the proposed physiological mechanisms, 27 published cohort studies in the last decade have produced mixed results for the associations of GI and GL with CHD. [28] [29] [30] [31] We therefore undertook a systematic review and meta-analysis of prospective cohort studies with healthy populations at baseline to determine whether associations exist between GI and GL with CHD.
Methods Data Sources and Study Selection
We conducted separate searches for all prospective cohort studies that assessed potential associations between glycemic index or load and primary incidence of CHD (including myocardial infarction [MI] or death due to CHD) in adults. We followed the meta-analysis of observational studies in epidemiology (MOOSE) guidelines for this report. 32 
Results
Search Results Figure 1 shows the flow of the literature applying the systematic search and selection strategies. In all, 473 eligible studies were identified by the search. A total of 10 studies with 12 GI reports [28] [29] [30] [31] 33, 35, 36, 42, 43 and 12 GL reports [28] [29] [30] [31] [33] [34] [35] [36] 42, 43 were selected for analyses. Two reports 28, 34 on the Nurses' Health Study provided data on the GL exposure; only the report with the larger subject numbers and longer followup was included in the GL analyses.
34,44

Cohort Characteristics
The study characteristics and their diet compositions are shown in Tables 1 and 2 , respectively. Of the 10 studies identified, 12 GI and 12 GL reports with CHD risk estimation were included in our analyses, with a total of 233 655 [28] [29] [30] [31] 33, 35, 36, 42, 43 and 240 936 [28] [29] [30] [31] [33] [34] [35] [36] 42, 43 subjects, respectively. During 6 to 25 years of follow-up, 6940 coronary events were recorded. All studies used Cox proportional hazard models for CHD risk estimation analyses, except for 1 study 43 which used restricted cubic spline models. The most common confounders adjusted for included age, BMI, and cigarette smoking, with full multivariate analyses outlined in Table 1 . All cohorts excluded those with documented CHD or major CHD risk factor at time of enrollment, with the exception of 1 that included a population 5% of whom had diabetes 35 but adjusted for diabetes status.
All analyses were stratified by sex. All studies used Cox proportional hazard models in their CHD risk estimation association analyses with GI and GL, except for Grau et al. 43 All studies had a healthy starting population at the beginning of follow-up except for Mursu et al, 35 who had a 5% diabetic population at the start.
*Number of Questionnaires Administered denotes number of administered questionnaires at the beginning of and throughout the study. †All studies adjusted for age, BMI, physical activity, alcohol intake, total energy, saturated fat intake. ‡Dietary fiber intake was adjusted for in all but 1 study. 29 food consumption patterns. 29, 35, 43 All studies used the Figure 3 , sex-specific subgroups). The female cohorts 31, 33, 34, 36, 42, 43 showed a larger, statistically significant association (DGL between mean of highest exposure and mean of reference=88.4±17.6 SE, RR=1. 55 
SE). The
figure is stratified by sex-specific subgroups with subtotal boxes in 2.1.1 and 2.1.2 summarizing the pooled analysis for women 28, 31, 33, 36, 42, 43 and for men, 29, 30, 33, 35, 43 respectively. The total analysis box represents the overall pooled analysis for both men and women. P values in circles are based on generic inverse variance (IV) methods in random-effects models and represent the significance for association of high-GI diets with CHD. The P value in a rectangle depicts the significance of differences between the subgroups. Interstudy heterogeneity was tested by Cochrane's Q (v 2 ) at a significance level of P<0.10 and quantified by I 2 . 38 CHD indicates coronary heart disease; GI, glycemic index.
There was significant evidence of heterogeneity in the female subset but not in the male subset.
Publication Bias
Funnel plots for each of the overall analyses were inspected for presence of publication bias (Figures 4 and 5) . Neither Begg's nor Egger's tests revealed significant evidence of publication bias in the overall analyses of GI and GL (P>0.115 for all). However, in the visual inspection of the GI funnel plot, the Grau et al 43 report on men appears to be an outlier and in the GL funnel plot, and the Grau et al 43 report on women appears to be an outlier (outside the pseudo 95% confidence limits).
Discussion
We believe that this analysis represents the most comprehensive meta-analysis of the data presented as quantiles of GI and/or GL. However, we were unable to include 2 studies in this analysis because of the expression of results as either the substitution of low GI carbohydrates for SFAs, rather than dietary GI analysis, or the incremental association of dietary GI with CHD rather than quantile presentation (ie, CHD risk per 5 GI unit increments). These studies indicated that in Danish 47 and Black American 44 men, positive benefits for cardiovascular events were seen related to consumption of lower GI foods. We demonstrated an overall increased relative risk of CHD of 11% in the comparison of the highest versus lowest quantile of GI and a 27% increased relative risk of CHD for the highest versus the lowest quantile of GL. The effect was seen only in women with 26% increased relative risk of CHD for GI and 55% for GL. The sex difference in the CHD response to the glycemic index was unexpected and may be the result of the larger total number of subjects in the female cohorts (n=177 887, CHD events=4260) than in the male cohorts (n=63 049, CHD events=2680) and our inability to include 2 studies, 1 from Denmark 47 and 1 from the United States, 44 both of which demonstrated adverse effects of high GI foods or diets on CHD outcomes in men. Furthermore, the 1 study 43 of men in the present analysis that showed a near-significant deleterious effect of low-GI diets was also responsible for the heterogeneity in the analysis. This study differed from the other studies of men in several respects. The proportion (54%) of smokers was almost twice that of the other studies, and BMI was somewhat lower (25.3 versus 26.1 kg/m 2 ); men with lower BMIs have been shown to be less susceptible to the Figure 3 . Pooled risk estimate of all prospective cohorts investigating the association of highest GL exposure with CHD events (including death and myocardial infarctions) relative to the reference exposure (DGL between mean of highest exposure and mean of reference=89.4±9.5 SE). The figure is stratified by sex-specific subgroups with subtotal boxes in 3.1.1 and 3.1.2 summarizing the pooled analysis for women 31, 33, 34, 36, 42, 43 and for men, 29, 30, 33, 35, 43 respectively. The total analysis box represents the overall pooled analysis for both men and women. P values in circles are based on generic inverse variance (IV) methods in random-effects models and represent the significance for association of high-GL diets with CHD. The P value in a rectangle depicts the significance of differences between the subgroups. Interstudy heterogeneity was tested by Cochrane's Q (v 2 ) at a significance level of P<0.10 and quantified by I 2 . 38 CHD indicates coronary heart disease; GI, glycemic index.
effects of GI on CHD risk. 48 There may also be another potential explanation for the difference between men and women, possibly a result of differences in diet reporting. For example, if women report more precisely, there would be less measurement error and hence better power. In addition, there may be more homogeneity (insufficient heterogeneity) in the diets of men and therefore a lack of the necessary power to detect potentially important relationships between dietary GI/GL and CHD risk in men. Despite these reservations there are reasons why women may be potentially more vulnerable to high glycemic index diets. Part of the protection that women have from CHD may be related to their high HDL-C levels. 49, 50 Higher glycemic index diets tend to reduce circulating HDL-C concentrations and thus disproportionately increase CHD risk in women, especially when postmenopausal. 51 At the same time, high-GI diets may raise TG levels, 52 which may also carry more risk for CHD in women than in men. 53, 54 Other factors that in general may contribute to the increased CHD risk with high-GI diets are blood pressure and CRP, both of which may be raised by high-GI diets. 52, 55 Conversely, acarbose, the a-glucosidase inhibitor that converts dietary carbohydrate to a low glycemic index form, has been shown to prevent hypertension and CHD events in the STOP NIDDM trial. 56 The link between low GI and GL diets and lower CHD risk is also substantiated by randomized clinical trials (RCTs) assessing the effects of dietary strategies low in GI and GL with low saturated fat content. A systematic review of such RCTs in overweight and obese subjects found that replacing refined carbohydrates with low-GI complex carbohydrates conferred more beneficial effects on CHD lipid risk factors when compared with complex starchy carbohydrates with higher GI. 57 There has also been emerging evidence on the positive effects of low-GI diets on CHD risk factors such as oxidative damage 58 and inflammation 22 in overweight/obese and type 2 diabetic individuals, respectively. In addition, metaanalyses of low-GI RCTs have shown beneficial effects on body weight and lipid profiles in obese and overweight subjects 21 as well as on glycemic control in type 2 diabetic subjects. 59 The current studies do not suggest a latency effect of GI or GL on CHD risk. Because no studies have a time frame shorter than 6 years, it is not possible to determine whether the effect is early, possibly from alterations in clotting factors, 60 or later due to reduction in the rate of atheroma formation secondary to oxidative damage. 61 An earlier meta-analysis that assessed the effect of dietary GI on several health outcomes including diabetes, CHD, and cancer also concluded that low-GI diets were protective for diabetes, CHD, and colon and breast cancers. 62 However, only 2 studies 28,29 were available to assess CHD outcome at the time of that analysis. In general, the glycemic index and glycemic load data were in agreement, although the magnitude of the CHD risk was greater based on the difference between the extreme quantiles of glycemic load. In the overall GL extreme quantile analysis there was significant heterogeneity that became nonsignificant when either the Grau et al 43 approach, using restricted cubic splines in Grau et al, 43 compared with the methods of analyses used in other reports. We could not find an explanation for the heterogeneity in the overall GL analysis due to the Sieri et al 33 report on women.
The weaknesses of the present study include the limited number of studies, the inability to include potentially relevant studies 44, 47 because of lack of necessary data, and the heterogeneity in the overall analyses, especially in the likely underpowered analyses of men. Another inherent limitation of observational analyses is the potential problem for residual confounding as well as the possibility of overadjusting, which remains an area of debate in epidemiology. 63 Perhaps, the most common limitation in meta-analyses of dietary studies is the combination of dietary data collected using multiple instruments. Although no change was found in our overall conclusions with post hoc sensitivity analyses removing the 4 29, 35, 43 reports with food diaries and interviews, because of the time frame of published reports, the GI and GL data were still compiled from various data sources. As such, our findings should be considered with caution, and further studies should be undertaken to allow sufficient power for subgroup analyses of dietary data sources. Although the reports included men and women from Holland, 29, 31, 36 Finland, 35 Denmark, 43 Sweden, 30, 42 Italy, 33 and the United States, 28,34 the majority of the population was white, limiting the racial diversity of this meta-analysis. However, it is noteworthy that our systematic review captured a report on African American men that, although not included because of lack of necessary data (ie, quantile analyses), showed that a 5-unit increase in GI conferred a 16% increase in CHD risk. 44 Further studies are required with a wider range of ethnic groups and more racial diversity both in women and especially in men because cohorts of men were likely underpowered. The strength of our study included the use of randomeffects models to allow assessment of heterogeneity to guide the sensitivity analyses. We further believe that our systematic review was strengthened by our efforts to acquire as much data as possible by contacting all study authors to include all relevant studies in our analyses.
Conclusion
We conclude that a reduction in the glycemic index and glycemic load may favorably affect CHD outcomes in women. Further studies are required to determine the effect of the glycemic index and load on CHD risk in men.
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